Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Tazocin (tn)
2. Zosyn (tn)
3. Piperacillin-tazobactam Mixt.
4. Piperacillin-tazobactam Mixture
5. Niosh/xi0191450
6. Piperacillin Sodium And Tazobactam
7. Dtxsid001016418
8. Tazobactam And Piperacillin (jp17)
9. Piperacillin-tazobactam Mixt. (4:1)
10. Tazobactam-piperacillin Mixt. (1:4)
11. Xi01914500
12. D02505
13. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 3-methyl-7-oxo-3-(1h-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, (2s-(2-alpha,3-beta,5-alpha))-, Mixt. With (2s-(2-alpha,5-alpha,6-beta(s*)))-6-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid (1:4)
14. Sodium;(2s,5r,6r)-6-[[(2s)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;(2s,3s,5r)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
Molecular Weight | 839.8 g/mol |
---|---|
Molecular Formula | C33H38N9NaO12S2 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 15 |
Rotatable Bond Count | 9 |
Exact Mass | 839.19790431 g/mol |
Monoisotopic Mass | 839.19790431 g/mol |
Topological Polar Surface Area | 315 Ų |
Heavy Atom Count | 57 |
Formal Charge | 0 |
Complexity | 1560 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
ABOUT THIS PAGE
12
PharmaCompass offers a list of Piperacillin + Tazobactam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Piperacillin + Tazobactam manufacturer or Piperacillin + Tazobactam supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Piperacillin + Tazobactam manufacturer or Piperacillin + Tazobactam supplier.
PharmaCompass also assists you with knowing the Piperacillin + Tazobactam API Price utilized in the formulation of products. Piperacillin + Tazobactam API Price is not always fixed or binding as the Piperacillin + Tazobactam Price is obtained through a variety of data sources. The Piperacillin + Tazobactam Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Piperacillin-tazobactam combination manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Piperacillin-tazobactam combination, including repackagers and relabelers. The FDA regulates Piperacillin-tazobactam combination manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Piperacillin-tazobactam combination API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Piperacillin-tazobactam combination manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Piperacillin-tazobactam combination supplier is an individual or a company that provides Piperacillin-tazobactam combination active pharmaceutical ingredient (API) or Piperacillin-tazobactam combination finished formulations upon request. The Piperacillin-tazobactam combination suppliers may include Piperacillin-tazobactam combination API manufacturers, exporters, distributors and traders.
click here to find a list of Piperacillin-tazobactam combination suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Piperacillin-tazobactam combination DMF (Drug Master File) is a document detailing the whole manufacturing process of Piperacillin-tazobactam combination active pharmaceutical ingredient (API) in detail. Different forms of Piperacillin-tazobactam combination DMFs exist exist since differing nations have different regulations, such as Piperacillin-tazobactam combination USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Piperacillin-tazobactam combination DMF submitted to regulatory agencies in the US is known as a USDMF. Piperacillin-tazobactam combination USDMF includes data on Piperacillin-tazobactam combination's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Piperacillin-tazobactam combination USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Piperacillin-tazobactam combination suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Piperacillin-tazobactam combination Drug Master File in Korea (Piperacillin-tazobactam combination KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Piperacillin-tazobactam combination. The MFDS reviews the Piperacillin-tazobactam combination KDMF as part of the drug registration process and uses the information provided in the Piperacillin-tazobactam combination KDMF to evaluate the safety and efficacy of the drug.
After submitting a Piperacillin-tazobactam combination KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Piperacillin-tazobactam combination API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Piperacillin-tazobactam combination suppliers with KDMF on PharmaCompass.
A Piperacillin-tazobactam combination written confirmation (Piperacillin-tazobactam combination WC) is an official document issued by a regulatory agency to a Piperacillin-tazobactam combination manufacturer, verifying that the manufacturing facility of a Piperacillin-tazobactam combination active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Piperacillin-tazobactam combination APIs or Piperacillin-tazobactam combination finished pharmaceutical products to another nation, regulatory agencies frequently require a Piperacillin-tazobactam combination WC (written confirmation) as part of the regulatory process.
click here to find a list of Piperacillin-tazobactam combination suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Piperacillin-tazobactam combination as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Piperacillin-tazobactam combination API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Piperacillin-tazobactam combination as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Piperacillin-tazobactam combination and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Piperacillin-tazobactam combination NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Piperacillin-tazobactam combination suppliers with NDC on PharmaCompass.
Piperacillin-tazobactam combination Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Piperacillin-tazobactam combination GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Piperacillin-tazobactam combination GMP manufacturer or Piperacillin-tazobactam combination GMP API supplier for your needs.
A Piperacillin-tazobactam combination CoA (Certificate of Analysis) is a formal document that attests to Piperacillin-tazobactam combination's compliance with Piperacillin-tazobactam combination specifications and serves as a tool for batch-level quality control.
Piperacillin-tazobactam combination CoA mostly includes findings from lab analyses of a specific batch. For each Piperacillin-tazobactam combination CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Piperacillin-tazobactam combination may be tested according to a variety of international standards, such as European Pharmacopoeia (Piperacillin-tazobactam combination EP), Piperacillin-tazobactam combination JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Piperacillin-tazobactam combination USP).